Skip to main content
Fig. 3 | Virology Journal

Fig. 3

From: Molecular transmission network analysis reveals the challenge of HIV-1 in ageing patients in China: elderly people play a crucial role in the transmission of subtypes and high pretreatment drug resistance in developed Eastern China, 2019–2023

Fig. 3

A: Frequency of HIV-1 pretreatment drug resistance (PDR) mutations to PIs, NRTIs, and NNRTIs. B: Level of HIV-1 PDR associated mutations to different ART drug among 136 newly diagnosed HIV/AIDS patients. PI, Protease inhibitor; NRTI, Nucleoside reverse transcriptase inhibitor; NNRTI, Non-nucleoside reverse transcriptase inhibitor; ATV/r:Atazanavir/ritonavir; FPV/R:Fosamprenavir/ritonavir; IDV/r:Indinavir/ritonavir; LPV/r:Lopinavir/ritonavir; NFV:Nelfinavir; SQV/r:Saquinavir/ritonavir; TPV/r: Ritonavir/ritonavir; ABC: Abacavir; AZT: Zidovudine; D4T: Stavudine; DDI: Didanosine; FTC: Emtricitabine; 3TC, Lamivudine; TDF, Tenofovir; DOR, Doravirine; EFV, Efavirenz; ETR: Etravirine; NVP: Nevirapine; RPV: Rilpivirine

Back to article page

Virology Journal

ISSN: 1743-422X